Engelsk

Eligibility Prostate Cancer NCT02238366

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult men, ≥18 years old, with recently diagnosed locally advanced or metastatic prostate cancer scheduled to receive androgen deprivation therapy as monotherapy or as concomitant and adjuvant therapy in association with radiation therapy, with a 1 or 3 month gnrh analogue triptorelin formulation
Beskrivning

Adult | Age | Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma | Antiandrogen therapy Scheduled | Therapeutic radiology procedure | GnRH Analog | Triptorelin

Datatyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C0600139
UMLS CUI [3,2]
C0205179
UMLS CUI [3,3]
C1517927
UMLS CUI [4]
C0936223
UMLS CUI [5,1]
C0279492
UMLS CUI [5,2]
C0205539
UMLS CUI [6]
C1522449
UMLS CUI [7]
C1518041
UMLS CUI [8]
C0077275
expected survival > 12 months.
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
patients having provided written informed consent.
Beskrivning

Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
patients mentally fit for completing a questionnaire.
Beskrivning

Patients Mentally alert | Questionnaire Completion

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0424536
UMLS CUI [2,1]
C0034394
UMLS CUI [2,2]
C0205197
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with any investigational drug within the last 3 months before study entry or planning to participate in a study.
Beskrivning

Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0013230
patients who already have been treated with a gnrh analogue within the last year.
Beskrivning

GnRH Analog preceding

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1518041
UMLS CUI [1,2]
C0332152
patients with hypersensitivity to gnrh, gnrh analogue, triptorelin or its excipients.
Beskrivning

Hypersensitivity GnRH | Hypersensitivity GnRH Analog | Triptorelin allergy | Hypersensitivity GnRH Excipient | Hypersensitivity GnRH Analog Excipient | Hypersensitivity Triptorelin Excipient

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0023610
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1518041
UMLS CUI [3]
C0571725
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0023610
UMLS CUI [4,3]
C0015237
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C1518041
UMLS CUI [5,3]
C0015237
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0077275
UMLS CUI [6,3]
C0015237
patients with a contraindication according to smpc.
Beskrivning

Medical contraindication

Datatyp

boolean

Alias
UMLS CUI [1]
C1301624
Tillbaka till toppen

Similar models

Eligibility Prostate Cancer NCT02238366

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age | Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma | Antiandrogen therapy Scheduled | Therapeutic radiology procedure | GnRH Analog | Triptorelin
Item
adult men, ≥18 years old, with recently diagnosed locally advanced or metastatic prostate cancer scheduled to receive androgen deprivation therapy as monotherapy or as concomitant and adjuvant therapy in association with radiation therapy, with a 1 or 3 month gnrh analogue triptorelin formulation
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0600139 (UMLS CUI [3,1])
C0205179 (UMLS CUI [3,2])
C1517927 (UMLS CUI [3,3])
C0936223 (UMLS CUI [4])
C0279492 (UMLS CUI [5,1])
C0205539 (UMLS CUI [5,2])
C1522449 (UMLS CUI [6])
C1518041 (UMLS CUI [7])
C0077275 (UMLS CUI [8])
Life Expectancy
Item
expected survival > 12 months.
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
patients having provided written informed consent.
boolean
C0021430 (UMLS CUI [1])
Patients Mentally alert | Questionnaire Completion
Item
patients mentally fit for completing a questionnaire.
boolean
C0030705 (UMLS CUI [1,1])
C0424536 (UMLS CUI [1,2])
C0034394 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs
Item
treatment with any investigational drug within the last 3 months before study entry or planning to participate in a study.
boolean
C0013230 (UMLS CUI [1])
GnRH Analog preceding
Item
patients who already have been treated with a gnrh analogue within the last year.
boolean
C1518041 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
Hypersensitivity GnRH | Hypersensitivity GnRH Analog | Triptorelin allergy | Hypersensitivity GnRH Excipient | Hypersensitivity GnRH Analog Excipient | Hypersensitivity Triptorelin Excipient
Item
patients with hypersensitivity to gnrh, gnrh analogue, triptorelin or its excipients.
boolean
C0020517 (UMLS CUI [1,1])
C0023610 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1518041 (UMLS CUI [2,2])
C0571725 (UMLS CUI [3])
C0020517 (UMLS CUI [4,1])
C0023610 (UMLS CUI [4,2])
C0015237 (UMLS CUI [4,3])
C0020517 (UMLS CUI [5,1])
C1518041 (UMLS CUI [5,2])
C0015237 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C0077275 (UMLS CUI [6,2])
C0015237 (UMLS CUI [6,3])
Medical contraindication
Item
patients with a contraindication according to smpc.
boolean
C1301624 (UMLS CUI [1])
Tillbaka till toppen